Literature DB >> 15818472

Virchow's Legacy: deep vein thrombosis and pulmonary embolism.

Jorge Cervantes1, Guillermo Rojas.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15818472     DOI： 10.1007/s00268-004-2056-0

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  11 in total

1.  Long-term outcome after pulmonary thromboendarterectomy.

Authors:  C J Archibald; W R Auger; P F Fedullo; R N Channick; K M Kerr; S W Jamieson; D P Kapelanski; C N Watt; K M Moser
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 2.  Pulmonary endarterectomy.

Authors:  S W Jamieson; D P Kapelanski
Journal:  Curr Probl Surg       Date:  2000-03       Impact factor: 1.909

Review 3.  The current role of thrombolytic therapy for pulmonary embolism.

Authors:  S Z Goldhaber
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

4.  Overview: pulmonary thromboembolism.

Authors:  L J Greenfield; T W Wakefield
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

5.  Rudolf Ludwig Carl Virchow (1821-1902): bibliography.

Authors:  L T Morton
Journal:  J Med Biogr       Date:  1993-02

Review 6.  Prevention of venous thromboembolism.

Authors:  G P Clagett; F A Anderson; W Geerts; J A Heit; M Knudson; J R Lieberman; G J Merli; H B Wheeler
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

7.  Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.

Authors:  H R Büller; M Gent; A S Gallus; J Ginsberg; M H Prins; R Baildon
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

Review 8.  Current vena cava filter devices and results.

Authors:  T A Whitehill
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

Review 9.  Low-molecular-weight heparin in the treatment of pulmonary embolism.

Authors:  W Ageno; A G Turpie
Journal:  Semin Vasc Surg       Date:  2000-09       Impact factor: 1.000

Review 10.  Current indications for caval interruption: should they be liberalized in view of improving technology?

Authors:  L J Greenfield; M C Proctor
Journal:  Semin Vasc Surg       Date:  1996-03       Impact factor: 1.000
View more
  6 in total

1.  Risk scores, prevention, and treatment of maternal venous thromboembolism.

Authors:  Wei Zhang; Jian Shen; Jing-Li Sun
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

2.  Acute infections and venous thromboembolism.

Authors:  M Schmidt; E Horvath-Puho; R W Thomsen; L Smeeth; H T Sørensen
Journal:  J Intern Med       Date:  2011-12-08       Impact factor: 8.989

3.  Risk Factors for Venous Thromboembolism following Thoracolumbar Surgery: Analysis of 43,777 Patients from the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2012.

Authors:  Arjun S Sebastian; Bradford L Currier; Sanjeev Kakar; Emily C Nguyen; Amy E Wagie; Elizabeth S Habermann; Ahmad Nassr
Journal:  Global Spine J       Date:  2016-02-17

Review 4.  Characteristics of Deep Venous Thrombosis in Isolated Lower Extremity Fractures and Unsolved Problems in Guidelines: A Review of Recent Literature.

Authors:  Wei-Guang Zhao; Wei-Li Zhang; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2022-05-27       Impact factor: 2.279

Review 5.  Graduated compression stockings as a prophylactic measure in venous thromboembolism and edema of lower limbs triggered by air travel: a systematic review of clinical trials.

Authors:  Lorenna Ferreira da Silva; Melissa Stephane Roberta Porto; Albert Bacelar de Sousa; Katia de Miranda Avena
Journal:  J Vasc Bras       Date:  2021-05-10

6.  Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1.

Authors:  Ke-Cheng Tang; Zhi-Peng Yang; Qiu Zeng; Jing Wang; Feng Guo; Yu Zhao
Journal:  Biosci Rep       Date:  2018-12-21       Impact factor: 3.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.